Rezultati pretrage - David J. Lederer

Detaljiziraj rezultate
  1. 1
    Selecting lung transplant candidates: where do current guidelines fall short?

    Selecting lung transplant candidates: where do current guidelines fall short? od J.L. Hook, David J. Lederer

    Izdano 2012
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  2. 2
    Micromechanics of Alveolar Edema

    Micromechanics of Alveolar Edema od Carrie E. Perlman, David J. Lederer, Jahar Bhattacharya

    Izdano 2010
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Screening High‐Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists

    Screening High‐Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists od Elana J. Bernstein, Dinesh Khanna, David J. Lederer

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  4. 4
    Frailty in Pulmonary and Critical Care Medicine

    Frailty in Pulmonary and Critical Care Medicine od Jonathan P. Singer, David J. Lederer, Matthew R. Baldwin

    Izdano 2016
    Preuzmi cijeli tekst
    Revisão
    Spremi u popis
    Spremljeno u:
  5. 5
    Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey

    Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey od Gregory P. Cosgrove, Pauline Bianchi, Sherry Danese, David J. Lederer

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  6. 6
    Delayed Access and Survival in Idiopathic Pulmonary Fibrosis

    Delayed Access and Survival in Idiopathic Pulmonary Fibrosis od Daniela Lamas, Steven M. Kawut, Emilia Bagiella, Nisha Philip, Selim M. Arcasoy, David J. Lederer

    Izdano 2011
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  7. 7
    Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis

    Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis od David J. Lederer, Selim M. Arcasoy, Jessie S. Wilt, F. D’Ovidio, Joshua Sonett, Steven M. Kawut

    Izdano 2006
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  8. 8
    Hypoalbuminemia and Early Mortality After Lung Transplantation: A Cohort Study

    Hypoalbuminemia and Early Mortality After Lung Transplantation: A Cohort Study od Matthew R. Baldwin, Selim M. Arcasoy, Ashish S. Shah, P. Christian Schulze, Julia Sze, Joshua Sonett, David J. Lederer

    Izdano 2012
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  9. 9
    Vascular Inflammation in Obesity and Sleep Apnea

    Vascular Inflammation in Obesity and Sleep Apnea od Sanja Jelić, David J. Lederer, Tessa Adams, Margherita Padeletti, P.C. Colombo, Phillip Factor, Thierry H. Le Jemtel

    Izdano 2010
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  10. 10
    Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial

    Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial od David J. Lederer, Matthew N. Bartels, Neil W. Schluger, Frances Brogan, Patricia Jellen, Byron Thomashow, Steven M. Kawut

    Izdano 2012
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  11. 11
    Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease

    Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease od Whitney D. Gannon, David J. Lederer, Mauer Biscotti, Azka Javaid, Nina Patel, Daniel Brodie, Matthew Bacchetta, Matthew R. Baldwin

    Izdano 2018
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  12. 12
    Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells

    Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells od Alexandros Strikoudis, Anna Cieślak, Lucas F. Loffredo, Ya‐Wen Chen, Nina Patel, Anjali Saqi, David J. Lederer, Hans-Willem Snoeck

    Izdano 2019
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  13. 13
    Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation

    Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation od David M. Vock, Michael T. Durheim, Wayne Tsuang, Catherine Copeland, Anastasios A. Tsiatis, Marie Davidian, Megan L. Neely, David J. Lederer, Scott M. Palmer

    Izdano 2016
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  14. 14
    Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial

    Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial od Toby M. Maher, Tamera J. Corte, Aryeh Fischer, Michael Kreuter, David J. Lederer, María Molina‐Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Vincent Cottin

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  15. 15
    Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis

    Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis od Michael Kreuter, David J. Lederer, María Molina‐Molina, Imre Noth, Claudia Valenzuela, Lutz Frankenstein, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, Vincent Cottin

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  16. 16
    A Prognostic Model for 6-Month Mortality in Elderly Survivors of Critical Illness

    A Prognostic Model for 6-Month Mortality in Elderly Survivors of Critical Illness od Matthew R. Baldwin, Wazim Narain, Hannah Wunsch, Neil W. Schluger, Joseph Cooke, Matthew J. Maurer, John W. Rowe, David J. Lederer, Peter B. Bach

    Izdano 2013
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  17. 17
    Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function

    Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function od Carlo Albera, Ulrich Costabel, Elizabeth A. Fagan, Marilyn K. Glassberg, Eduard Gorina, Lisa Lancaster, David J. Lederer, Steven D. Nathan, Dominique Spirig, Jeff Swigris

    Izdano 2016
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  18. 18
    Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation

    Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation od David J. Lederer, Jessie S. Wilt, F. D’Ovidio, Matthew Bacchetta, Lori Shah, Shankari Ravichandran, J. -L. J. Lenoir, Brenda Klein, Joshua Sonett, Selim M. Arcasoy

    Izdano 2009
    Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  19. 19
    Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)

    Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and... od Toby M. Maher, Michael Kreuter, David J. Lederer, Kevin K. Brown, Wim Wuyts, Nadia Verbruggen, Simone Stutvoet, Ann Fieuw, Paul Ford, Walid Abi‐Saab, Marlies Wijsenbeek

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  20. 20
    Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis

    Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis od Steven D. Nathan, Ulrich Costabel, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David J. Lederer, Carlos A.C. Pereira, Benjamin Trzaskoma, Elizabeth Morgenthien, Susan L. Limb, Athol U. Wells

    Izdano 2018
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: